Edition:
India

Syneos Health Inc (SYNH.OQ)

SYNH.OQ on NASDAQ Stock Exchange Global Select Market

66.54USD
9:23pm IST
Change (% chg)

$0.10 (+0.15%)
Prev Close
$66.44
Open
$67.00
Day's High
$67.00
Day's Low
$66.08
Volume
18,432
Avg. Vol
284,139
52-wk High
$74.22
52-wk Low
$30.34

Latest Key Developments (Source: Significant Developments)

Syneos Health Announces Senior Notes Offering
Wednesday, 18 Nov 2020 

Nov 18 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH ANNOUNCES SENIOR NOTES OFFERING.SYNEOS HEALTH ANNOUNCES SENIOR NOTES OFFERING.SYNEOS HEALTH INC - COMMENCED OFFERING OF $500.0 MILLION SENIOR NOTES IN A PRIVATE OFFERING.SYNEOS HEALTH INC - INTENDS TO ENTER INTO AN AMENDMENT TO CREDIT AGREEMENT GOVERNING ITS EXISTING SENIOR SECURED CREDIT FACILITIES.SYNEOS HEALTH INC - INTENDS TO ENTER INTO AMENDMENT TO CREDIT AGREEMENT, PURSUANT TO WHICH, CO EXPECTS TO EXTEND MATURITY DATE THEREOF TO AUGUST 2024.  Full Article

Syneos Health Approves New Stock Repurchase Program To Take Effect On January 1, 2021
Wednesday, 18 Nov 2020 

Nov 17 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH INC - APPROVED NEW STOCK REPURCHASE PROGRAM THAT WILL TAKE EFFECT ON JANUARY 1, 2021.SYNEOS HEALTH INC - NEW REPURCHASE PROGRAM WILL SUCCEED EXISTING PROGRAM THAT EXPIRES ON DECEMBER 31, 2020.SYNEOS HEALTH INC - NEW STOCK REPURCHASE PROGRAM AUTHORIZES TO REPURCHASE UP TO $300 MILLION OF CLASS A COMMON STOCK.  Full Article

Medadvisor To Acquire Us-Based Adheris Health
Monday, 2 Nov 2020 

Nov 2 (Reuters) - Medadvisor Ltd ::MEDADVISOR LTD - MDR TO ACQUIRE US-BASED ADHERIS HEALTH & TARGETS $45M RAISE-MDR.AX.MEDADVISOR LTD - ENTERED AGREEMENT TO ACQUIRE ADHERIS FOR UP TO USD $34.5M FROM SYNEOS HEALTH.UNDER PLACEMENT, SHARES TO BE ISSUED AT $0.45 PER SHARE.  Full Article

Syneos Health To Acquire Synteract
Thursday, 29 Oct 2020 

Oct 28 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH TO ACQUIRE SYNTERACT, A TOP CRO PROVIDER TO EMERGING BIOPHARMA.SYNEOS HEALTH INC - UPON TRANSACTION CLOSING, SYNTERACT WILL MAINTAIN ITS BRAND, OPERATING AS A SYNEOS HEALTH BUSINESS UNIT.  Full Article

Syneos Health Announces Pricing Of Secondary Offering Of Common Stock
Wednesday, 16 Sep 2020 

Sept 16 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH ANNOUNCES PRICING OF SECONDARY OFFERING OF COMMON STOCK.SAYS SECONDARY OFFERING OF 7 MILLION SHARES OF COMMON STOCK PRICED AT $59.75PER SHARE.  Full Article

Syneos Health Reports Q2 Adjusted Earnings Per Share $0.58
Thursday, 6 Aug 2020 

Aug 6 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH REPORTS SECOND QUARTER 2020 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.58.Q2 GAAP EARNINGS PER SHARE $0.04.Q2 REVENUE $1.013 BILLION VERSUS REFINITIV IBES ESTIMATE OF $990.8 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.48 -- REFINITIV IBES DATA.SEES 2020 REVENUE OF $4,470 MILLION TO $4,570 MILLION.SEES 2020 ADJUSTED DILUTED EARNINGS PER SHARE OF $3.16 TO $3.38.  Full Article

Syneos Health Signs New Service Agreement With Pfizer
Monday, 13 Jul 2020 

July 13 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH SIGNS NEW SERVICE AGREEMENT WITH PFIZER.SYNEOS HEALTH INC - UNDER TERMS, PFIZER HAS RIGHT TO EXTEND TERM FOR UP TO AN ADDITIONAL TWO YEARS.SYNEOS HEALTH INC - FINANCIAL DETAILS OF AGREEMENT WERE NOT DISCLOSED..SYNEOS HEALTH - HAS SIGNED NEW THREE-YEAR AGREEMENT WITH PFIZER INC. TO DELIVER GLOBAL PRODUCT DEVELOPMENT SOLUTIONS TO SUPPORT PFIZER'S PORTFOLIO.  Full Article

Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52
Wednesday, 3 Jun 2020 

June 3 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH INC SEES Q2 ADJUSTED EARNINGS PER SHARE $0.48 - $0.52 - SEC FILING.SYNEOS HEALTH INC SEES Q2 REVENUE IN RANGE OF $1.0 BILLION - $1.02 BILLION.SYNEOS HEALTH INC SEES Q2 GAAP LOSS PER SHARE $0.03 - $0.06.  Full Article

Syneos Health Withdraws Financial Guidance For Year Ending Dec. 31, 2020
Tuesday, 7 Apr 2020 

April 7 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH INC - EXPECTS AGGREGATE FINANCIAL RESULTS FOR THREE MONTHS ENDED MARCH 31, 2020 TO BE IN LINE WITH ITS PREVIOUSLY ISSUED GUIDANCE RANGE.SYNEOS HEALTH INC - WITHDRAWING COMPANY'S FINANCIAL GUIDANCE FOR YEAR ENDING DECEMBER 31, 2020.SYNEOS HEALTH INC - CURRENTLY ANTICIPATES THAT DISRUPTION CAUSED BY COVID-19 WILL IMPACT Q2 REVENUE AND WILL LIKELY EXTEND INTO AT LEAST Q3 OF 2020.SYNEOS HEALTH INC - IMPLEMENTED PROACTIVE CASH CONSERVATION INITIATIVES, INCLUDING DELAYING SOME CAPITAL EXPENDITURES.  Full Article

Syneos Health Reports Q4 Adjusted Earnings Per Share $1.03
Thursday, 20 Feb 2020 

Feb 20 (Reuters) - Syneos Health Inc ::SYNEOS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $1.03.Q4 GAAP EARNINGS PER SHARE $0.86.Q4 REVENUE $1.213 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.19 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $1.01 -- REFINITIV IBES DATA.REAFFIRMS FY 2020 ADJUSTED EARNINGS PER SHARE VIEW $3.58 TO $3.78.SAYS REAFFIRMING FULL-YEAR 2020 REVENUE GUIDANCE OF $4,880.0 MILLION TO $5,000.0 MILLION.FY2020 EARNINGS PER SHARE VIEW $3.65, REVENUE VIEW $4.94 BILLION -- REFINITIV IBES DATA.  Full Article

BRIEF-Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52

* SYNEOS HEALTH INC SEES Q2 ADJUSTED EARNINGS PER SHARE $0.48 - $0.52 - SEC FILING